E. Sánchez-Larios, R. D. Giacometti, S. Hanessian
SHORT COMMUNICATION
[3]
[4]
a) Y. Hayashi, Y. Kim, Y. Hayashi, Chairul, Biosci. Biotechnol.
Biochem. 1992, 56, 1302–1303; b) M. Zhang, B. P. Ying, I.
Kubo, J. Nat. Prod. 1992, 55, 1057–1062.
a) J. M. Cassady, T. K. Lightner, T. G. McCloud, J. A.
Hembree, S. R. Byrn, C. Chang, J. Org. Chem. 1984, 49, 942–
945; b) J. A. Hembree, C.-J. Chang, J. L. McLaughlin, J. M.
Cassady, D. J. Watts, E. Wenkert, S. F. Fonseca, J.
De Paiva Campello, Phytochemistry 1979, 18, 1691–1694; c)
S. M. Kupchan, S. L. Baxter, M. F. Ziegler, P. M. Smith, R. F.
Bryan, Experientia 1975, 31, 137–138.
porting Information). It is clear that with few exceptions,
the α-pyrones and their corresponding dihydropyrone ana-
logs exhibit promising antiproliferative activity in spite of
their relatively simple structures.
[5]
For isolation of nagilactone F, see: Y. Hayashi, J. Yokoi, Y. Wa-
tanabe, T. Sakan, Y. Masudo, R. Yamamoto, Chem. Lett. 1972,
1, 759–762.
[6]
[7]
[8]
[9]
For isolation of urbalactone, see: B. Dasgupta, B. A. Burke,
K. L. Stuart, Phytochemistry 1981, 20, 153–156.
For reviews on the biosynthesis of podolactones, see: a) S. Itô,
M. Kodama, Heterocycles 1976, 4, 595–624; b) ref. 1a.
S. Hanessian, N. Boyer, G. Reddy, B. Deschênes-Simard, Org.
Lett. 2009, 11, 4640–4643.
A. F. Barrero, J. F. Sánchez, J. Elmarabet, D. Jiménez-
González, F. Macías, A. M. Simonet, Tetrahedron 1999, 55,
7289–7304.
a) Y. Hayashi, T. Matsumoto, T. Hyono, N. Nishikawa, M.
Uemura, M. Nishizawa, M. Togami, T. Sakan, Tetrahedron
Lett. 1979, 20, 3311–3314; b) Y. Hayashi, T. Matsumoto, M.
Nishizawa, M. Togami, T. Hyono, N. Nishikawa, M. Uemura,
T. Sakan, J. Org. Chem. 1982, 47, 3428–3433.
Figure 4. Antiproliferative activity of selected α-pyrones 2 and di-
hydropyrones 5 on the A2780 ovarian cancer cell line. See the Sup-
porting Information for details.
[10]
Conclusions
[11]
[12]
[13]
S. D. Burke, M. E. Kort, S. M. S. Strickland, H. M. Organ,
L. A. Silks III, Tetrahedron Lett. 1994, 35, 1503–1506.
J. T. A. Reuvers, A. de Groot, J. Org. Chem. 1986, 51, 4594–
4599.
In conclusion, we have adapted Schreiber’s gold(I)-cata-
lyzed synthesis of 3,4,5-trisubstituted α-pyrones to the total
synthesis of a ring A aromatic congener of the podolactone
urbalactone. The scope of the cyclization was expanded to
include a number of substituted aryl acetylenic esters, which
were further manipulated and subjected to Friedel–Crafts
cyclization to give novel tricyclic dihydronaphthalenes har-
boring a fused α-pyrone ring. A number of α-pyrone inter-
mediates were found to exhibit single digit micromolar anti-
proliferative activity on A2780 ovarian cancer cells. Further
studies to probe the scope of the Schreiber’s gold(I)-cata-
lyzed cyclization and synthetic efforts toward the total syn-
thesis of podolactones are in progress.
a) T. Luo, S. L. Schreiber, Angew. Chem. Int. Ed. 2007, 46,
8250–8253–8401; Angew. Chem. 2007, 119, 8398–8401; b) T.
Luo, M. Dai, S.-L. Zheng, S. L. Schreiber, Org. Lett. 2011, 13,
2834–2836.
For selected reviews, see: a) A. S. K. Hashmi, F. D. Toste
(Eds.), Modern Gold Catalyzed Synthesis, Wiley-VCH,
Weinheim, Germany, 2012; b) A. Fürstner, Acc. Chem. Res.
2013, 46, 925–938; c) Z. Li, C. Brouwer, C. He, Chem. Rev.
2008, 108, 3239–3265.
For related cyclizations, see: a) Y. Shigemasa, M. Yasui, S.
Ohrai, M. Sasaki, H. Sashiwa, H. Saimoto, J. Org. Chem. 1991,
56, 910–912; b) A. W. Sromek, A. V. KelЈin, V. Gevorgyan, An-
gew. Chem. Int. Ed. 2004, 43, 2280–2282; Angew. Chem. 2004,
116, 2330–2332; c) S. Wang, L. Zhang, J. Am. Chem. Soc. 2006,
128, 8414–8415; d) J. Zhao, C. O. Hughes, F. D. Toste, J. Am.
Chem. Soc. 2006, 128, 7436–7437; e) N. Asao, H. Aikawa, S.
Tago, K. Umetsu, Org. Lett. 2007, 9, 4299–4302.
[14]
[15]
Supporting Information (see footnote on the first page of this arti-
cle): Detailed experimental procedures; 1H NMR and 13C NMR
spectra for all new compounds; and crystallographic data for 2p,
10, 11, and 24.
[16]
[17]
For the preparation of aryl acetylenic esters and other experi-
mental details see the Supporting Information.
The color of the reaction mixture changes from bright yellow
to dark yellow-brown during the course of the cyclization reac-
tions.
During the exploration of the reaction conditions for the ad-
dition of the vinyl cuprate to model substrate 3a, copper salts
such as CuBr·SMe2, CuI, and CuCN·2LiCl were tested. At
first, we noticed that the initial preparation of the vinyl cuprate
at –78 °C followed by the addition of a THF solution of 3a
resulted in a ca. 2:1 mixture of 4a/5a. If 3a or 3b was first
premixed with LiCl in THF at –78 °C followed by the addition
of vinylmagnesium bromide, a ca. 12:1 mixture of 4a/5a was
obtained; for details see the Supporting Information.
a) S. Ohira, Synth. Commun. 1989, 19, 561–564; b) S. Müller,
B. Liepold, G. J. Roth, H. J. Bestmann, Synlett 1996, 521–522;
c) J. Pietruszka, A. Witt, Synthesis 2006, 4266–4268.
a) N.-W. Jan, H.-J. Liu, Org. Lett. 2006, 8, 151–153; b) J. R.
Martinelli, D. A. Watson, D. M. M. Freckmann, T. E. Barder,
S. L. Buchwald, J. Org. Chem. 2008, 73, 7102–7107.
Acknowledgments
E. S. L. thanks Consejo Nacional de Ciencia y Tecnología (CON-
ACyT), Mexico for a Research Postdoctoral Fellowship. The Natu-
ral Sciences and Engineering Research Council of Canada
(NSERC) and Sigma-Tau (USA) are acknowledged for generous
financial support. The authors thank Dr. Giuseppe Giannini
(Sigma-Tau, Italy) for the anticancer tests. R. D. G. is grateful to
NSERC for a postgraduate scholarship (CGS-D).
[18]
[1] a) A, F. Barrero, J. F. Quilez del Moral, M. M. Herrador, Stud.
Nat. Prod. Chem. 2003, 28, 453–516; b) A. K. Banerjee, M. S.
Laya, H. R. Mora, E. V. Cabrera, Curr. Org. Chem. 2008, 12,
1050–1070.
[2] T. Hosoe, K. Nozawa, T. C. Lumley, R. S. Currah, K. Fukush-
ima, K. Takizawa, M. Miyaji, K.-I. Kawai, Chem. Pharm. Bull.
1999, 47, 1591–1597.
[19]
[20]
5668
www.eurjoc.org
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2014, 5664–5669